Suppr超能文献

脂蛋白脂肪酶之后会发生什么?高甘油三酯血症的实验和临床研究中脂肪组织脂肪酸低掺入量(FIAT)情况。

What happens after lipoprotein lipase? A low fatty acid incorporation into adipose tissue (FIAT) in hypertriglyceridaemia-experimental and clinical studies.

作者信息

Walldius G

出版信息

Int J Obes. 1981;5(6):707-16.

PMID:7319689
Abstract

The Fatty acid Incorporation into human Adipose Tissue (FIAT), the metabolic step after the hydrolysis of plasma triglyceride (TG)-bound fatty acids (FA) by lipoprotein lipase, was studied by an in-vitro technique to investigate its role and reactions to various substrates, drug and dietary treatments in hypertriglyceridaemia (HTG). We found that FIAT was reduced, P less than 0.001, in patients with HTG and a recent myocardial infarction compared to normotriglyceridaemic (NTG) patients. Patients with very high plasma TG levels had the lowest FIAT. There were highly significant positive correlations between FIAT in several subcutaneous regions and omental fat with highest activities in the omental fat. FIAT increased approximately linearly with increasing medium FA concentrations in both NTG and HTG patients. Low values were more common in HTG. In both groups, however, the rate of fatty acid mobilizing lipolysis was significantly decreased when FA increased. FA thus seems to have important effects on both FIAT and rate of lipolysis. FIAT was increased when rate of fatty acid mobilization was inhibited in vitro by the beta-blocker oxprenolol. FIAT decreased, P less than 0.05 and lipolysis increased, P less than 0.01 after one week of treatment with an adenosine derivate BM 11.189. Serum TG were not affected in that study but decreased, P less than 0.001, when HTG patients were treated by diet and clofibrate for two weeks presumably because this treatment increased FA-removal, ie FIAT. The results suggest that variations in the FIAT activity seems to play an important role in determining plasma TG levels.

摘要

通过体外技术研究了脂肪酸掺入人体脂肪组织(FIAT),这是脂蛋白脂肪酶水解血浆甘油三酯(TG)结合脂肪酸(FA)后的代谢步骤,以探讨其在高甘油三酯血症(HTG)中对各种底物、药物和饮食治疗的作用及反应。我们发现,与正常甘油三酯血症(NTG)患者相比,HTG且近期发生心肌梗死的患者的FIAT降低,P<0.001。血浆TG水平非常高的患者的FIAT最低。几个皮下区域的FIAT与网膜脂肪之间存在高度显著的正相关,网膜脂肪中的活性最高。在NTG和HTG患者中,FIAT均随培养基中FA浓度的增加而大致呈线性增加。低值在HTG中更常见。然而,在两组中,当FA增加时,脂肪酸动员性脂解速率均显著降低。因此,FA似乎对FIAT和脂解速率都有重要影响。当β受体阻滞剂氧烯洛尔在体外抑制脂肪酸动员速率时,FIAT增加。用腺苷衍生物BM 11.189治疗一周后,FIAT降低,P<0.05,脂解增加,P<0.01。在该研究中,血清TG未受影响,但当HTG患者接受饮食和氯贝丁酯治疗两周时,血清TG降低,P<0.001,这可能是因为这种治疗增加了FA清除,即FIAT。结果表明,FIAT活性的变化似乎在决定血浆TG水平方面起重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验